174 related articles for article (PubMed ID: 37949355)
1. IL-6/JAK2-dependent G6PD phosphorylation promotes nucleotide synthesis and supports tumor growth.
Qiu X; Ye H; Li X; Li D; Jiang L; Liu R; Zhao Z; He D
Mol Metab; 2023 Dec; 78():101836. PubMed ID: 37949355
[TBL] [Abstract][Full Text] [Related]
2. Rapid phosphorylation of glucose-6-phosphate dehydrogenase by casein kinase 2 sustains redox homeostasis under ionizing radiation.
Hao Y; Ren T; Huang X; Li M; Lee JH; Chen Q; Liu R; Tang Q
Redox Biol; 2023 Sep; 65():102810. PubMed ID: 37478541
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
4. PBX3 promotes pentose phosphate pathway and colorectal cancer progression by enhancing G6PD expression.
Luo X; Wei M; Li W; Zhao H; Kasim V; Wu S
Int J Biol Sci; 2023; 19(14):4525-4538. PubMed ID: 37781025
[TBL] [Abstract][Full Text] [Related]
5. NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.
Li Z; He Y; Li Y; Li J; Zhao H; Song G; Miyagishi M; Wu S; Kasim V
Oncogene; 2021 Dec; 40(50):6736-6747. PubMed ID: 34657129
[TBL] [Abstract][Full Text] [Related]
6. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
[TBL] [Abstract][Full Text] [Related]
7. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract][Full Text] [Related]
8. PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3.
Sun M; Sheng H; Wu T; Song J; Sun H; Wang Y; Wang J; Li Z; Zhao H; Tan J; Li Y; Chen G; Huang Q; Zhang Y; Lan B; Liu S; Shan C; Zhang S
Biochem Pharmacol; 2021 Oct; 192():114736. PubMed ID: 34411567
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers.
Ahamed A; Hosea R; Wu S; Kasim V
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139067
[TBL] [Abstract][Full Text] [Related]
10. A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
Yang H; Chen D; Wu Y; Zhou H; Diao W; Liu G; Li Q
Cancer Metab; 2023 Dec; 11(1):27. PubMed ID: 38111012
[TBL] [Abstract][Full Text] [Related]
11. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
12. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
13. c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
Ma H; Zhang F; Zhou L; Cao T; Sun D; Wen S; Zhu J; Xiong Z; Tsau MT; Cheng ML; Hung LM; Zhou Y; Li Q
Oncogene; 2021 Apr; 40(14):2567-2580. PubMed ID: 33686238
[TBL] [Abstract][Full Text] [Related]
14. H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth.
Lu C; Yang D; Klement JD; Colson YL; Oberlies NH; Pearce CJ; Colby AH; Grinstaff MW; Liu Z; Shi H; Ding HF; Liu K
Oncogene; 2022 Apr; 41(18):2651-2662. PubMed ID: 35351997
[TBL] [Abstract][Full Text] [Related]
15. The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway.
Tang Y; Li W; Qiu L; Zhang X; Zhang L; Miyagishi M; Zhao H; Wu S; Kasim V
Oncogenesis; 2023 Mar; 12(1):17. PubMed ID: 36977688
[TBL] [Abstract][Full Text] [Related]
16. G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway.
Li R; Ke M; Qi M; Han Z; Cao Y; Deng Z; Qian J; Yang Y; Gu C
Exp Hematol Oncol; 2022 Oct; 11(1):77. PubMed ID: 36271440
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.
Rao X; Duan X; Mao W; Li X; Li Z; Li Q; Zheng Z; Xu H; Chen M; Wang PG; Wang Y; Shen B; Yi W
Nat Commun; 2015 Sep; 6():8468. PubMed ID: 26399441
[TBL] [Abstract][Full Text] [Related]
18. DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
Su Z; Gao A; Li X; Zou S; He C; Wu J; Ding WQ; Zhou J
Front Oncol; 2021; 11():706337. PubMed ID: 34354953
[TBL] [Abstract][Full Text] [Related]
19. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
20. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
